September 13, 2020 Comments Off on Patent delisted for Astrazeneca Ab drug BYDUREON Posted in: Uncategorized
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty patents…
The post Patent delisted for Astrazeneca Ab drug BYDUREON appeared first…
September 13, 2020 Comments Off on Patent delisted for Helsinn Hlthcare drug ALOXI Posted in: Uncategorized
Annual Drug Patent Expirations for ALOXI Aloxi is a drug marketed by Helsinn Hlthcare and is included in two NDAs. It is available from three suppliers. There are thirteen patents…
The post Patent delisted for Helsinn Hlthcare drug ALOXI appeared first…
